Life Insurance of India (NSE:LICI) Research & Development: ₹0 Mil (TTM As of Mar. 2026)


NSE:LICI Life Insurance Corporation of India NSE:LICI
73 GF Score
Price ₹431.25
GF Value ₹482.89
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Life Insurance of India Research & Development?

Life Insurance of India NSE:LICI +1.87% 73 Research & Development is ₹0 Mil as of Mar. 2026. GuruFocus rates NSE:LICI with a GF Score™ of 73/100 and a GF Value™ of ₹482.89 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Life Insurance of India's Research & Development for the three months ended in Mar. 2026 was ₹0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0 Mil.

Life Insurance of India  (NSE:LICI) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Life Insurance of India Research & Development Related Terms

Life Insurance of India Research & Development Historical Data

* Premium members only.

The historical data trend for Life Insurance of India's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Life Insurance of India Research & Development Chart

Life Insurance of India Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Life Insurance of India Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:LICI
73GF Score
Life Insurance Corporation of India NSE:LICI
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Life Insurance of India Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹0 Mil mean?
Life Insurance of India (NSE:LICI) has a Research & Development of ₹0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Life Insurance of India and its competitors.
Is Life Insurance of India's Research & Development too high?
Life Insurance of India's current Research & Development is ₹0 Mil. Overall, Life Insurance of India has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Life Insurance of India's Research & Development compare to AFL and MET?
Life Insurance of India's Research & Development of ₹0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Life Insurance of India and its competitors. Life Insurance of India's current Research & Development is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Life Insurance of India stock overvalued right now?
Based on GuruFocus' analysis, Life Insurance of India (NSE:LICI) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹482.89, compared to a current price of ₹431.25 — trading 10.7% below its estimated fair value. The current Research & Development is ₹0 Mil. Life Insurance of India's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Life Insurance of India (NSE:LICI), the current Research & Development is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Life Insurance of India (NSE:LICI) Overvalued in 2026?

Based on GuruFocus' analysis, Life Insurance of India stock appears to be undervalued. The current stock price of ₹431.25 is trading 10.7% below its estimated GF Value™ of ₹482.89. GuruFocus considers Life Insurance of India to be Modestly Undervalued.

Key valuation signals for NSE:LICI:

  • Research & Development: ₹0 Mil
  • GF Value™: ₹482.89 vs. price of ₹431.25 (10.7% below fair value)
  • GF Score™: 73/100 with 2 warning signs

No single metric tells the full story. See the NSE:LICI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Life Insurance of India Business Description

Other Exchanges 543526:India
Address Jeevan Bima Marg, Central Office, Yogakshema, Nariman Point, Mumbai, MH, IND, 400021
Life Insurance Corporation of India is engaged in providing life insurance in India. The company offers diversified product portfolio covering various segments across individual products and group products.
73GF Score

Get the complete analysis for NSE:LICI

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹431.25
Price
₹482.89
GF Value